CURX vs PEG · $8.9M cap vs P/E 18, rev $6.40B
Curanex Pharmaceuticals Inc Common Stock (CURX) versus Public Service Enterprise Group Inc (PEG) — a side-by-side from cached financials, not a winner call.
Curanex Pharmaceuticals Inc Common Stock (CURX) is a biotechnology company listed on NASDAQ.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
CURX does not have a complete income-statement cache yet.
Latest reported PEG revenue for 2026-06-30 was $6.40B. Net income was $1.07B. Revenue was up 66.4% from 2026-03-31 to 2026-06-30. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
CURX currently screens at market cap $8.9M. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Not investment advice. Open the CURX and PEG stock pages for the full models.
Not investment advice.